# Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmacokinetics, and Biological Effects

> **NCT07738562** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Hadassah Medical Organization** · enrollment: 15 (estimated)

## Conditions studied

- Preeclampsia (PE)
- Hypertension ,Pregnancy

## Interventions

- **DRUG:** Dipyridamole 75 MG

## Key facts

- **NCT ID:** NCT07738562
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-09
- **Final completion:** 2028-09
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07738562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07738562, "Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmacokinetics, and Biological Effects". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07738562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*